| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| P819 | ADS bibcode | 2013PLoSO...876927H |
| P356 | DOI | 10.1371/JOURNAL.PONE.0076927 |
| P932 | PMC publication ID | 3799911 |
| P698 | PubMed publication ID | 24204707 |
| P5875 | ResearchGate publication ID | 258350690 |
| P50 | author | Taiping He | Q59685345 |
| P2093 | author name string | Wenjuan Wang | |
| Liren Hu | |||
| Hongjiao Li | |||
| Haiqing Luo | |||
| P2860 | cites work | Global cancer statistics | Q22241238 |
| Bias in meta-analysis detected by a simple, graphical test | Q24685585 | ||
| Structural insights into molecular function of the metastasis-associated phosphatase PRL-3 | Q27642885 | ||
| Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints | Q27860640 | ||
| Measuring inconsistency in meta-analyses | Q27860655 | ||
| A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. | Q27860879 | ||
| Constitutive activation of signal transducers and activators of transcription 3 correlates with better prognosis, cell proliferation and hypoxia-inducible factor-1α in human gastric cancer. | Q53397588 | ||
| High PRL-3 expression in human gastric cancer is a marker of metastasis and grades of malignancies: an in situ hybridization study | Q79603710 | ||
| Association of tyrosine PRL-3 phosphatase protein expression with peritoneal metastasis of gastric carcinoma and prognosis | Q80647954 | ||
| Statistical aspects of the analysis of data from retrospective studies of disease | Q27860916 | ||
| Practical methods for incorporating summary time-to-event data into meta-analysis | Q28131754 | ||
| PRL-3 expression in metastatic cancers | Q28189073 | ||
| A phosphatase associated with metastasis of colorectal cancer | Q28198115 | ||
| Global burden of cancers attributable to infections in 2008: a review and synthetic analysis | Q29620303 | ||
| PCBP1 suppresses the translation of metastasis-associated PRL-3 phosphatase. | Q33627071 | ||
| Therapeutic potential of PRL-3 targeting and clinical significance of PRL-3 genomic amplification in gastric cancer | Q33863328 | ||
| Meta-regression models to address heterogeneity and inconsistency in network meta-analysis of survival outcomes | Q34436139 | ||
| Overexpression of Snail is associated with lymph node metastasis and poor prognosis in patients with gastric cancer | Q34476703 | ||
| Targeting protein tyrosine phosphatases for anticancer drug discovery | Q34789961 | ||
| Expression and clinical role of protein of regenerating liver (PRL) phosphatases in ovarian carcinoma | Q34874940 | ||
| Upregulation of protein tyrosine phosphatase type IVA member 3 (PTP4A3/PRL-3) is associated with tumor differentiation and a poor prognosis in human hepatocellular carcinoma | Q36484951 | ||
| Method guidelines for Cochrane Musculoskeletal Group systematic reviews. | Q36645821 | ||
| PRL-3 is essentially overexpressed in primary colorectal tumours and associates with tumour aggressiveness | Q36977592 | ||
| PRL PTPs: mediators and markers of cancer progression | Q37068759 | ||
| Expression of phosphatase regenerating liver 3 is an independent prognostic indicator for gastric cancer | Q37149601 | ||
| Expression of CD133 in the cytoplasm is associated with cancer progression and poor prognosis in gastric cancer | Q37468314 | ||
| PRL‐3 phosphatase and cancer metastasis | Q37807363 | ||
| PRL-3, an emerging marker of carcinogenesis, is strongly associated with poor prognosis. | Q37835341 | ||
| Over-expression of phosphatase of regenerating liver-3 correlates with tumor progression and poor prognosis in nasopharyngeal carcinoma | Q38423558 | ||
| High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients | Q39916955 | ||
| PTP4A3 (PRL-3) expression correlate with lymphatic metastases in gastric cancer. | Q42743399 | ||
| Prognostic significance of high phosphatase of regenerating liver-3 expression in patients with gastric cancer who underwent curative gastrectomy | Q43678272 | ||
| Overexpression of phosphatase of regenerating liver-3 in breast cancer: association with a poor clinical outcome | Q43685496 | ||
| Phosphatase of regenerating liver-3 as a prognostic biomarker in histologically node-negative gastric cancer. | Q46020801 | ||
| Elevated PRL-3 expression was more frequently detected in the large primary gastric cancer and exhibits a poor prognostic impact on the patients | Q46170338 | ||
| TP53 codon 72 and intron 3 polymorphisms and mutational status in gastric cancer: an association with tumor onset and prognosis | Q47635771 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e76927 | |
| P577 | publication date | 2013-10-18 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Poor prognosis of phosphatase of regenerating liver 3 expression in gastric cancer: a meta-analysis | |
| P478 | volume | 8 |
| Q41127993 | Genomic gain of the PRL-3 gene may represent poor prognosis of primary colorectal cancer, and associate with liver metastasis |
| Q36918028 | Phosphatase PTP4A3 Promotes Triple-Negative Breast Cancer Growth and Predicts Poor Patient Survival |
| Q52590705 | Phosphatase of regenerating liver-3 (PRL-3) is overexpressed in classical Hodgkin lymphoma and promotes survival and migration. |
| Q92073923 | Prognostic Biomarkers for Gastric Cancer: An Umbrella Review of the Evidence |
Search more.